Post COVID-19 Immunological Era
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 744
Special Issue Editors
Interests: infection and immunity; immunotherapy; check-point inhibitors and stimulators; T cell response against SARS-CoV-2; viral immunity; translational research; clinical trials; bacterial and viral vaccines; immune mechanism behind antivirals; host-pathogen immunology
Special Issues, Collections and Topics in MDPI journals
Interests: immunology; immune response; immunity; auto-immunity; tuberculosis; infection; vaccines, host–pathogen interactions
Interests: immunology; immunology in type 1 diabetes; host-parasite interaction; immunomodulation by parasite; autoimmunity and inflammation; T cell biology
Special Issues, Collections and Topics in MDPI journals
Interests: molecular microbiology; COVID-19 management and treatment; microbial pathogenesis control with antimicrobial compounds; biodegradation through novel strains-characterization and activity; microbial biotechnology
Special Issue Information
Dear Colleagues,
Coronavirus disease 2019 (COVID-19) has changed all attributes of immunological research. This area concerns inflammatory diseases, infectious diseases, cancer, pulmonary diseases, vascular diseases, and autoimmune diseases, along with all immunopathologies, including effects on the immune and hematopoietic systems. Early studies have reported the immune dysregulation caused by COVID-19 in terms of changes in cellular and humoral immune responses, and its possible involvement in regulating or worsening the immune regulatory environment. In some of patients, hyperimmune activation leads to multisystem inflammatory syndrome in children (MIS-C) and long-term COVID-19 in children and adults. Continuous exposure to long-COVID-19 virus fragments in the body can act as a superantigen that may cause autoimmune symptoms. Infection-fighting cytokines mistakenly attack the body’s organs (overactivation).
We welcome research papers on immune system involvement in relation to COVID-19 including, but not limited to, the following topics:
- Long COVID and immune response;
- Long COVID treatment;
- Post-COVID-19 immune pathology;
- Immune therapies and COVID-19;
- COVID-19 and inflammatory diseases;
- COVID-19 and immune-mediated disorders;
- Post-COVID-19 infection and autoimmunity.
Dr. Lalit Batra
Dr. Namdev S. Togre
Dr. Nitin P. Amdare
Dr. Dharmender Kumar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- immune response
- immune therapies and COVID-19
- COVID-19 and inflammatory diseases
- COVID-19 and immune-mediated disorders
- post-COVID-19 infection and immunology
